Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Prostatic Neoplasms 142Breast Neoplasms 97Lung Neoplasms 71Brain Neoplasms 66Glioblastoma 59Carcinoma, Non-Small-Cell Lung 53Glioma 52Pancreatic Neoplasms 39Neoplasms 39Neoplasm Metastasis 36Colorectal Neoplasms 31Carcinoma, Hepatocellular 30Lymphoma, Large B-Cell, Diffuse 27Carcinoma, Renal Cell 27Multiple Myeloma 26Squamous Cell Carcinoma of Head and Neck 25Rectal Neoplasms 21Melanoma 21Ovarian Neoplasms 20Astrocytoma 20Urinary Bladder Neoplasms 18Lymphoma, Follicular 18Uterine Cervical Neoplasms 17Colonic Neoplasms 17Head and Neck Neoplasms 16Lymphoma 15Esophageal Neoplasms 15Sarcoma 14Lymphoma, Mantle-Cell 14Lymphoma, B-Cell 14

Interventions

Megestrol Acetate 7Progestins 3Medroxyprogesterone Acetate 3Progesterone 2Letrozole 2Hysteroscopy 2Blood Specimen Collection 2Biopsy 2Atorvastatin 2semaglutide 1ricin A-GnRH conjugate 1estradiol, norethindrone drug combination 1Tirzepatide 1Tamoxifen 1Surveys and Questionnaires 1Sampling Studies 1Rosuvastatin Calcium 1Restraint, Physical 1Resistance Training 1Pterocarpus marsupium 1Observation 1Nutrition Assessment 1Metformin 1Magnetic Resonance Spectroscopy 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Intrauterine Devices 1Immunohistochemistry 1Hysterectomy 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Endometrial Hyperplasia × Magnetic Resonance Spectroscopy × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡